MYH7 mutation is associated with mitral valve leaflet elongation in patients with obstructive hypertrophic cardiomyopathy

• Published in: Heliyon 2024-07, Vol.10 (14), p.e34727, Article e34727
• Main Authors: Guo, Xinli, Huang, Manyun, Song, Changpeng, Nie, Changrong, Zheng, Xinxin, Zhou, Zhou, Wang, Shuiyun, Huang, Xiaohong
• Format: Article
• Language: English
• Subjects: Cardiac magnetic resonance imaging; Mitral valve leaflet elongation; MYH7 gene variation; Obstructive hypertrophic cardiomyopathy
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2024.e34727

Mitral valve (MV) leaflet elongation is recognized as a primary phenotypic expression of hypertrophic cardiomyopathy (HCM) that contributes to obstruction. This study investigates the correlation between MV length and genotype mutations in the two predominant genes, myosin-binding protein C (MYBPC3), and the β-myosin heavy chain (MYH7) in patients with obstructive HCM (OHCM). Among the 402 OHCM patients, there were likely pathogenic or pathogenic variations in MYH7 (n = 94) and MYBPC3 (n = 76), along with a mutation-negative group (n = 212). Compared to genotype-negative patients, genotype-positive individuals exhibited elongated MV length, thicker interventricular septum, and increased instances of late gadolinium enhancement. Notably, MYH7 mutations were associated with a more severe disease trajectory than MYBPC3 mutations. After adjusting for potential confounders, multivariate linear regression analysis revealed that MYH7 gene mutations and left ventricular volume were independently associated with MV leaflet elongation. The study indicates that mutations in MYH7 and hemodynamics factors are significant risk factors for elongated MV leaflet. Consequently, regular assessment of MV length, especially in patients with MYH7 mutation and enlarged LV volume, is crucial for timely preoperative strategic planning and improved prognosis.